Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine Disinfectant Intervention in Therapy Dogs
NCT04171817Phase 4Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- May 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorhexidine + cymenol gel in methicillin-resistant Staphylococcus aureus infection (MRSA), Clostridium difficile infection (CDI), Pseudomonas aeruginosa infection, sponsored by Johns Hopkins Bloomberg School of Public Health. Started May 2023; status: completed.
02
Drugs
chlorhexidine + cymenol gel
03
Conditions
methicillin-resistant Staphylococcus aureus infection (MRSA)Clostridium difficile infection (CDI)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT04171817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04171817.